Ally Financial Inc. Acquires New Shares in Intuitive Surgical, Inc. $ISRG

Ally Financial Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 10,000 shares of the medical equipment provider's stock, valued at approximately $3,977,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Pinnacle Holdings LLC bought a new position in Intuitive Surgical in the 2nd quarter valued at approximately $41,000. Kirtland Hills Capital Management LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth $628,000. Compass Financial Management LLC acquired a new stake in Intuitive Surgical in the second quarter valued at $30,000. Alta Advisers Ltd acquired a new stake in Intuitive Surgical in the second quarter valued at $565,000. Finally, Heartland Bank & Trust Co bought a new position in Intuitive Surgical during the 2nd quarter worth $791,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical News Summary

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Operating margin is widening. Intuitive Surgical’s operating margin has expanded in each of the past three years, suggesting improving efficiency and earnings quality even as U.S. procedure growth moderates. Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening
• Positive Sentiment: Wall Street remains broadly constructive. Analysts generally view ISRG favorably, with a consensus “Moderate Buy” rating and price targets substantially above recent trading levels. Recent upgrades and bullish commentary point to confidence in the da Vinci platform’s long-term growth. Is Wall Street Bullish or Bearish on Intuitive Surgical Stock?
• Positive Sentiment: Asia-Pacific capacity is expanding. A new manufacturing plant in Penang, Malaysia, is intended to increase regional capacity and support demand for robotic-assisted surgery, strengthening ISRG’s international growth opportunity. Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
• Neutral Sentiment: The company faces an execution test. Investors are weighing whether Intuitive can sustain system placements, procedure growth and recurring instrument revenue while expanding internationally and navigating a more cautious healthcare spending environment. Why Is Intuitive Surgical Facing an Execution Test?
• Negative Sentiment: Growth and valuation remain concerns. Investors continue to digest management’s cautious procedure-growth outlook of roughly 13.5%–15.5% for 2026, along with an estimated tariff impact on gross margin. With ISRG trading well below its prior high but still at a premium earnings multiple, valuation compression may continue if growth slows further. Intuitive Surgical Slides as Investors Digest Cautious Outlook
• Negative Sentiment: Insider selling adds a modest overhang. An executive vice president sold a small position under a pre-arranged Rule 10b5-1 plan. The transaction is not necessarily a fundamental warning, but broader recent insider activity has consisted predominantly of sales rather than purchases. Why Is Intuitive Surgical Stock Trending After Hours?

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $378.81 on Monday. The stock has a market cap of $133.83 billion, a P/E ratio of 43.39, a P/E/G ratio of 2.74 and a beta of 1.47. The company's 50 day moving average price is $388.47 and its two-hundred day moving average price is $436.27. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to analysts' expectations of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business's revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.81 earnings per share. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, SVP Iman Jeddi sold 5,625 shares of the company's stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares in the company, valued at approximately $2,718,014.65. This represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the firm's stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the sale, the director directly owned 179 shares of the company's stock, valued at $70,364.90. This represents a 28.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,283 shares of company stock worth $7,015,429 over the last 90 days. Corporate insiders own 0.60% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. decreased their price objective on Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating for the company in a report on Friday, July 17th. KeyCorp reiterated an "overweight" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating for the company in a research report on Friday, July 17th. Piper Sandler restated an "overweight" rating on shares of Intuitive Surgical in a research note on Friday. Finally, HSBC downgraded shares of Intuitive Surgical from a "buy" rating to a "hold" rating and set a $391.00 price objective on the stock. in a report on Thursday, July 30th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus price target of $508.68.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source